About Fluoropharma Medical (OTCMKTS:FPMI)
FluoroPharma Medical, Inc., formerly Commercial E-Waste Management Inc., is a biopharmaceutical company specializing in discovering, developing and commercializing molecular imaging pharmaceuticals with applications in the area of cardiology. The Company operates through biopharmaceutical research and development segment. It is focused on the development of cardiovascular imaging agents that can detect and assess acute and chronic forms of coronary artery disease (CAD). It has two clinical-stage molecular imaging pharmaceutical product candidates: Flourine-18 (18-F) TPP (BFPET), which includes a ((18F)-labeled cationic lipophilic tetraphenylphosphonium ion (18-F TPP) as an imaging agent designed for use in stress-testing for patients with presumptive or proven CAD, and 18-F FCPHA (CardioPET), which includes Trans-9-(18F)-Fluoro-3, 4-Methyleneheptadecanoic Acid (18-F FCPHA) as a molecular imaging agent designed to assess myocardial blood flow and metabolism in patients with CAD.
Industry, Sector and Symbol
Trailing P/E Ratio-1.33318520164426
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Book Value($0.30) per share
Price / Book-0.40
Return on EquityN/A
Return on AssetsN/A
Fluoropharma Medical (OTCMKTS:FPMI) Frequently Asked Questions
What is Fluoropharma Medical's stock symbol?
Fluoropharma Medical trades on the OTCMKTS under the ticker symbol "FPMI."
How were Fluoropharma Medical's earnings last quarter?
Fluoropharma Medical Inc (OTCMKTS:FPMI) released its earnings results on Friday, August, 14th. The biopharmaceutical company reported ($0.05) earnings per share for the quarter, topping analysts' consensus estimates of ($0.06) by $0.01. View Fluoropharma Medical's Earnings History.
When will Fluoropharma Medical make its next earnings announcement?
Who are some of Fluoropharma Medical's key competitors?
Some companies that are related to Fluoropharma Medical include Sunshine Heart (CHFS), ESSA Pharma (EPIX), Strata Skin Sciences (SSKN), Secure Point Technologies (IMSC), Mateon Therapeutics (MATN), Lombard Medical (EVARF), Rosetta Genomics (ROSG), Delcath Systems (DCTHD), Dextera Surgical (DXTR), TearLab (TEAR), BG Medicine (BGMD), Affymax (AFFY), Tetralogic Pharmaceuticals (TLOG), Imris (IMRSQ) and Echo Therapeutics (ECTE).
Who are Fluoropharma Medical's key executives?
Fluoropharma Medical's management team includes the folowing people:
- Walter W. Witoshkin, Interim Chairman of the Board, Independent Director (Age 69)
- Thomas H. Tulip Ph.D., President, Chief Executive Officer, Director (Age 62)
- Tamara Rhein, Chief Financial Officer (Age 42)
- W. Austin Lewis IV, Director (Age 40)
How do I buy Fluoropharma Medical stock?
Shares of Fluoropharma Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Fluoropharma Medical's stock price today?
One share of Fluoropharma Medical stock can currently be purchased for approximately $0.12.
How big of a company is Fluoropharma Medical?
Fluoropharma Medical has a market capitalization of $4.11 million. The biopharmaceutical company earns $-2,040,000.00 in net income (profit) each year or ($0.09) on an earnings per share basis. Fluoropharma Medical employs 4 workers across the globe.
How can I contact Fluoropharma Medical?
Fluoropharma Medical's mailing address is 8 Hillside Avenue Suite 108, Montclair NJ, 07042. The biopharmaceutical company can be reached via phone at 973-744-1565 or via email at [email protected]
MarketBeat Community Rating for Fluoropharma Medical (FPMI)MarketBeat's community ratings are surveys of what our community members think about Fluoropharma Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Fluoropharma Medical (OTCMKTS:FPMI) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Fluoropharma Medical (OTCMKTS:FPMI) Earnings History and Estimates Chart
Fluoropharma Medical (OTCMKTS FPMI) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|3/30/2018|| || || || || || || || |
Fluoropharma Medical (OTCMKTS:FPMI) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Fluoropharma Medical (OTCMKTS:FPMI)
No dividend announcements for this company have been tracked by MarketBeat.com
Fluoropharma Medical (OTCMKTS FPMI) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 36.90%
Fluoropharma Medical (OTCMKTS FPMI) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|1/7/2014||Johan M Spoor||CEO||Buy||10,000||$0.50||$5,000.00|| |
|11/26/2012||Johan M Spoor||CEO||Buy||10,000||$0.76||$7,600.00|| |
|9/12/2012||Johan M Spoor||CEO||Buy||50,000||$0.80||$40,000.00|| |
Fluoropharma Medical (OTCMKTS FPMI) News Headlines
|FluoroPharma Announces Closing of Stock Buyback Transaction|
finance.yahoo.com - January 10 at 5:41 PM
|FluoroPharma and Philips Collaborate on Image Management for CardioPET Phase II Clinical Trial|
finance.yahoo.com - October 5 at 8:54 AM
|FLUOROPHARMA MEDICAL, INC. Files SEC form 8-K, Material Modification to Rights of Security Holders|
biz.yahoo.com - March 2 at 5:31 PM
|FLUOROPHARMA MEDICAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equit|
biz.yahoo.com - December 6 at 11:00 AM
|FluoroPharma Medical (FPMI), Philips (PHG) Enter CardioPET Phase II Image Management Collaboration|
www.streetinsider.com - October 19 at 5:28 PM
|FLUOROPHARMA MEDICAL, INC. Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Of|
biz.yahoo.com - September 30 at 5:24 PM
|FLUOROPHARMA MEDICAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Amendments to Articles of|
biz.yahoo.com - August 18 at 5:04 PM
Fluoropharma Medical (OTCMKTS:FPMI) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Fluoropharma Medical (OTCMKTS FPMI) Stock Chart for Tuesday, January, 16, 2018